Global External Beam Radiotherapy Market Research Report
- Report Code: EX 1000
- Publish Date: Upcoming
The Global External Beam Radiotherapy Market is driven by changing cancer treatment technology and growing number of cancer patients. The market value of this market was $4,108 million in 2013 and is estimated to be $4,820 million by 2018, at a CAGR of 3.20%. The External Beam Radiotherapy Market is the largest segment of $4,108 million radiotherapy devices market. High Energy Linear Accelerators segment accounts the largest share with 80% of the global external beam radiotherapy market.
The report “External Beam Radiotherapy Market Forecast, 2012-2018”, analyzes the market in terms of devices such as compact advanced radiotherapy systems, proton radiotherapy Systems, and electron emitting high energy Linear Accelerators (LINAC). All the segments of external beam radiotherapy will experience a positive growth till 2018 with an increase in cancer patient pool, increased awareness for procedures, and sophisticated diagnostic techniques. With a market value of $3,299 million and $541million, the segments of high energy LINAC and compact advance radiotherapy systems have been accounting 80% and 13% in terms of the total external beam radiotherapy devices market. Both the markets of external beam radiotherapy have been witnessing maximum growth because of increase in cancer patient pool. Technologies of External Beam Radiotherapy are Intensity Modulated Radiation Therapy (IGRT), Image Guided Radiotherapy, Stereotactic Technology, 3D Conformal Radiotherapy, Proton Beam Therapy, Volumetric Modulated Arc Therapy, Adaptive Radiation Therapy and Tomotherapy.
In North America (US, Canada), Europe (Germany, France, Italy, Spain, UK), and Asia (India, China, Japan) the rising rates of cancer population have been driving the market growth. The external beam radiotherapy market growth for external beam radiotherapy is significantly higher in North America because it is always inclined to the newer techniques while comparatively slow-moving markets such as Europe and Japan are maturing using both old and new technologies. North America is the most dynamic, highly competitive and the largest market for external beam radiotherapy devices globally.
The U.S. and Europe comprise the maximum share of external beam radiotherapy market but developing countries such as Asian countries and other regions of the world are adopting new policies to welcome this therapeutic procedure to fight against cancer.
Prevalence of cancer worldwide, registering 7.4 million (53%) in males and 6.7 million (47%) in females, with a male and female ratio of 10:9. In 2012, there were an estimated 14.1 million new cases of cancer in the world. In 2014, there is an estimate of 1,665,540 new cancer cases to be diagnosed and 585,720 cancer deaths in the US alone. Cancer remains the second most common cause of death in the US, accounting for nearly one of every four deaths.
The report provides an extensive competitive landscaping of companies operating in this market. The key players of the market covered in this report are Varian Medical Systems, ELEKTA AB, Accuray Incorporated, Siemens, IBA S.A, Covidien Ltd., ProTom International,Inc., and Mevion Medical Systems, Inc. The details of segment and country-specific company shares, news and deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies is also covered in the report.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of external beam radiotherapy products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence and patient pool of prostate cancer, cancer in female breast and genital organs, lung and pleura cancer, head and neck cancer, colorectal cancer, spine cancer and brain cancer
- Disease progression (pattern analysis)
Procedure Volume Data
- Number of prostate cancer, brain cancer, lungs, and head and neck cancer surgeries performed annually in each country tracked till sub-segment level.
Surgeon’s/Physician’s Perception Analysis
- Fast turn-around analysis of surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of radiotherapy devices in various countries.
- Procedural investment in major countries for different types of cancer such as prostate cancer, brain cancer, lungs, head and neck cancer.
Competitive Intelligence
- The company share analysis of radiotherapy devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for radiotherapy devices.
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Cancer Centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Prostate Cancer
4.2 Breast and female genital organs Cancers
4.3 Lung and pleura Cancers
4.4 Head and neck cancers
4.5 Colorectal Cancer
4.6 Spine Cancer
4.7 Brain Cancer
5 By Segments
5.1 Compact Advanced Radiotherapy Systems
5.2 Proton Radiotherapy Systems
5.3 Electron emitting high energy linear accelerators (Linac)
6 By Technologies
6.1 Intensity Modulated Radiation Therapy (IGRT)
6.2 Image Guided Radiotherapy
6.3 Stereotactic Technology
6.4 3D Conformal Radiotherapy
6.5 Proton Beam Therapy
6.6 Volumetric Modulated Arc Therapy
6.7 Adaptive Radiation Therapy
6.8 Tomotherapy
7 By Geographies
7.1 North America
7.2 Europe
7.3 Asia
7.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Global Compact Advanced Radiotherapy Systems Market The Global Compact Advance Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $541 million in 2013 and expected to be $663 million by 2018, growing at a CAGR of 4.1%. The Compact Advance Radiotherapy Systems Market analyzes the market of devices by 3 segments such as Cyberknife, Gamma Knife, and TomoTherapy system.The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Global Proton Radiotherapy Systems Market The Global Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $322 million in 2013 and expected to be $388 million by 2018, growing at a CAGR of 3.8%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Global Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The Global High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $3299 million in 2013 and expected to be $3769 million by 2018, growing at a CAGR of 2.7%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Cyberknife Cyberknife and TomoTherapy and Gamma Knife adds up to total |
Upcoming |
|
|
TomoTherapy TomoTherapy and Cyberknife and Gamma Knife adds up to total |
Upcoming |
|
|
Gamma Knife Gamma Knife and Cyberknife and TomoTherapy adds up to total |
Upcoming |
|
|
Cyclotron for Proton Therapy Cyclotron for Proton Therapy and Synchrotron for Proton Therapy adds up to total |
Upcoming |
|
|
Synchrotron for Proton Therapy Synchrotron for Proton Therapy and Cyclotron for Proton Therapy adds up to total |
Upcoming |
|
|
North American External Beam Radiotherapy Devices Market The North American External Beam Radiotherapy Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1427.1 million in 2013 and expected to be $1571.7 million by 2018, growing at a CAGR of 2.0%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
European External Beam Radiotherapy Devices Market The European External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $702.5 million in 2013 and expected to be $784.3 million by 2018, growing at a CAGR of 2.2%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
Asian External Beam Radiotherapy Devices Market The Asian External Beam Radiotherapy Devices Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $699.2 million in 2013 and expected to be $919.6 million by 2018, growing at a CAGR of 5.6%. The Radiotherapy Devices Market analyzes the market of devices by 3 segments such as Compact Advanced Radiotherapy Systems, Proton Radiotherapy Systems and Electron emitting high energy linear accelerators (Linac).The prominent players in the Radiotherapy Devices Market globally are Varian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien. |
Upcoming |
|
|
North American Compact Advanced Radiotherapy Systems Market The North American market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $246.6 million in 2013 and is expected to reach $281.9 million by 2018, growing at a CAGR of 2.7% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
|
|
European Compact Advanced Radiotherapy Systems Market The European market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $96.0 million in 2013 and is expected to reach $124.3 million by 2018, growing at a CAGR of 5.3% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
|
|
Asian Compact Advanced Radiotherapy Systems Market The Asian market for compact advanced radiotherapy systems, mainly driven by rapidly changing cancer treatment technology and growing number of cancer patients, was valued at $90.8 million in 2013 and is expected to reach $118.6 million by 2018, growing at a CAGR of 5.5% during the forecast period. The report analyzes the market under three product segments: CyberKnife, Gamma Knife, and TomoTherapy. Varian Medical Systems, Elekta AB, Accuray Incorporated, Siemens, Ion Beam Applications (IBA) SA, Covidien plc, ProTom International Inc., and Mevion Medical Systems, Inc. are the key players in this market. |
Upcoming |
|
|
North American Proton Radiotherapy Systems Market The North American Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $106.6 million in 2013 and expected to be $122.1 million by 2018, growing at a CAGR of 2.7%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
European Proton Radiotherapy Systems Market The European Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $82.1 million in 2013 and expected to be $95.0 million by 2018, growing at a CAGR of 3.0%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Asian Proton Radiotherapy Systems Market The Asian Proton Radiotherapy Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $32.7 million in 2013 and expected to be $46.6 million by 2018, growing at a CAGR of 7.4%. The Proton Radiotherapy Systems Market analyzes the market of devices by 2 segments such as Cyclotron for proton therapy, and Synchrotron for proton therapy. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
North American Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The North American High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $1073.8 million in 2013 and expected to be $1167.7 million by 2018, growing at a CAGR of 1.7%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
European Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The European High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $524.4 million in 2013 and expected to be $565 million by 2018, growing at a CAGR of 1.5%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
|
|
Asian Electron Emitting High Energy Linear Accelerators (Linac) Systems Market The Asian High Energy Linear Accelerators(LINAC) Systems Market is mainly driven by rapidly changing Cancer treatment technology and Growing number of cancer patients.The Market was pegged at $575.4 million in 2013 and expected to be $754.4million by 2018, growing at a CAGR of 5.6%. High Energy Linear Accelerators(LINAC) Systems Market analyzes the market of devices by segments by technology such as IMRT, IGRT, stereotactic, adaptive radiation therapy, volumetric modulated arc therapy and others. The prominent players in the Radiotherapy Devices Market globally areVarian Medical Systems, Elekta AB, Accuray Incorporation, Siemens, IBA S.A, covidien, Protom international Inc, Mevion Medical Systems, Inc. |
Upcoming |
